Puma Biotechnology, Inc.PBYINASDAQ
Loading
Operating Expenses Over TimeContracting
Percentile Rank21
3Y CAGR-3.8%
5Y CAGR-9.3%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
-3.8%/yr
vs -16.8%/yr prior
5Y CAGR
-9.3%/yr
Recent acceleration
Acceleration
+13.0pp
Accelerating
Percentile
P21
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
8 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $132.90M | -1.6% |
| 2024 | $135.10M | -3.7% |
| 2023 | $140.31M | -6.0% |
| 2022 | $149.22M | -20.7% |
| 2021 | $188.16M | -12.9% |
| 2020 | $216.14M | -30.5% |
| 2019 | $311.04M | -0.0% |
| 2018 | $311.10M | -1.1% |
| 2017 | $314.50M | +13.7% |
| 2016 | $276.60M | - |